US2023172947A1PendingUtilityA1

Methods and compositions for treating endometrial cancer

Assignee: HOPE CITYPriority: Sep 15, 2017Filed: Jul 6, 2022Published: Jun 8, 2023
Est. expirySep 15, 2037(~11.1 yrs left)· nominal 20-yr term from priority
Inventors:Thanh Dellinger
A61K 31/09A61K 31/57A61K 9/08A61K 9/10A61K 9/0053A61K 9/2004A61K 9/0095A61P 35/00A61K 9/48
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Provided herein are, inter alia, methods and compositions for treating cancer in a subject in need thereof comprising a therapeutically effective amount of a stilbenoid compound and a progestin.

Claims

exact text as granted — not AI-modified
1 . A method of treating cancer in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of (i) pterostilbene or a pharmaceutically acceptable salt thereof; and (ii) megestrol or a pharmaceutically acceptable salt thereof. 
     
     
         2 - 65 . (canceled)

Join the waitlist — get patent alerts

Track US2023172947A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.